Lymphoma
Innate Pharma halts lymphomas trials after patient death, but key study continues
Anika Sharma
Innate Pharma has encountered a safety issue in its lymphoma program, resulting in the FDA imposing a partial clinical hold ...
CAR T-Cell Therapy in Hematological Malignancies: A Breakthrough or a Bust?
Anika Sharma
Hematological malignancies are cancers that affect the blood, bone marrow, and lymph nodes. They include leukemia, lymphoma, and multiple myeloma. ...
EMA Accepts Filing for Odronextamab to Address Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-Cell Lymphoma
Anika Sharma
Regeneron Pharmaceuticals achieved a significant milestone with the European Medicines Agency (EMA) accepting the Marketing Authorization Application (MAA) for odronextamab, ...
FDA rejects Citius’ resurrected IL-2 lymphoma treatment
SG Tylor
Source – Citius Pharmaceuticals The FDA has declined Citius Pharmaceuticals’ request to market Lymphir, an updated version of a lymphoma ...
Roche’s Columvi (glofitamab) for patients with R/R diffuse large B-cell lymphoma has received approval from the European Commission
SG Tylor
Source – Roche On 11 July 2023 Roche announced that the European Commission (EC) has given conditional approval for Columvi ...
